Genotypic and Phenotypic Predictors of the Magnitude of Response to Tenofovir Disoproxil Fumarate Treatment in Antiretroviral‐Experienced Patients

Results from 2 placebo-controlled intensification trials of tenofovir disoproxil fumarate (DF) in treatmentexperienced human immunodeficiency type 1 (HIV-1)-infected patients (n = 332) were integrated to determine the effects of resistance at baseline on HIV-1 RNA response. In these trials, there wa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Michael D. Miller, Nicolas Margot, Biao Lu, Lijie Zhong, Shanshan Chen, Andrew Cheng, Michael Wulfsohn
Natura: Artigo
Lingua:inglese
Pubblicazione: 2004
Accesso online:https://doi.org/10.1086/381784
https://academic.oup.com/jid/article-pdf/189/5/837/6022789/189-5-837.pdf
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!